-Reuters
DA Davidson Maintains Buy on A.O. Smith, Lowers Price Target to $65
DA Davidson analyst Matt Summerville maintains A.O. Smith (NYSE:AOS) with a Buy and lowers the price target from $75 to $65.
Qualcomm CEO Says Implementing Further Spending Reductions, Streamlining Operations
-Reuters
Related Posts
SoftBank Wants To Launch a Third Vision Fund, To Recoup Ballooning Losses Of The Previous Ones
Global tech investor Softbank Group Corp (OTC: SFTBY) explored the launch of a new giant startup investment fund after the poor performance of its two earlier funds,
IPA Provides Update On Growth Strategy And Recent Share Price Movement
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("IPA" or the "Company"), an AI-driven biotherapeutic research and technology company wishes to provide an update on its overall growth strategy,
Ocuphire Announces Late Breaking Presentation On APX3330 ZETA-1 Clinical Data At American Diabetes Association Annual Conference
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders, today announced